for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

India's Cadila gets regulatory nod to repurpose Hepatitis C drug for COVID-19

BENGALURU, April 23 (Reuters) - India’s Cadila Healthcare Ltd received approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19, the drugmaker said on Friday. (Reporting by Sachin Ravikumar in Bengaluru)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up